UCI: Tour de France champion, Froome failed drugs test
Union Cycliste Internationale (UCI), cycling’s governing body, said on Wednesday, that four-time Tour de France winner Chris Froome failed a drugs test during the Vuelta race in September.
The UCI did not suspend Froome from competing, but asked the British Team Sky driver to provide more information on violating the permitted level of legal asthma medication Salbutamol in his system.
The team said he had taken no more than the permissible amount of Salbutamol, adding that Froome had declared his use of the medication.
The 32-year-old rider suffered from asthma since childhood and had been affected by symptoms during the Vuelta a Espana, the Tour of Spain, which he went on to win.
Froome did not participate in any tournament since then, but he declared his intention to take part in the three major tours, France, Spain and Italy, in 2018.
How to submit an Op-Ed: Libyan Express accepts opinion articles on a wide range of topics. Submissions may be sent to firstname.lastname@example.org. Please include ‘Op-Ed’ in the subject line.
- Libya’s HCS invites applicants for key state roles - December 31, 2023
- UK calls on Iran to prevent escalation in Israel-Hamas conflict - November 05, 2023
- Libyan Interior Minister: Immigrant shelter costs a fortune - November 05, 2023